XLR Medical Corp.
XLRM
Other OTC1.23
USD
-0.17
- -
XLR Medical Corp.
XLRM
(Other OTC)
Recent
price
1.23
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- XLR Medical Corp. XLR Medical Corp. (XLRM) operates as a shell company seeking business combination opportunities through mergers, acquisitions, or similar transactions. The company generates no core products or operational services at present, having previously engaged in the CBD sector following its April 2021 acquisition of CBD Brand Partners, LLC from Mammoth Crest Capital, LLC, which involved hemp-derived supplements and cosmetics marketed under the Bloomios, Inc. name; however, it currently reports zero sales, assets, and income with a focus shifted to blank-check activities. Founded in 2000 and headquartered in Long Beach, New York, XLR Medical Corp. functions primarily in the shell companies industry on U.S. over-the-counter markets, targeting opportunistic deals without specified geographic operations beyond its U.S. base. Recent changes include a 1-for-50 reverse stock split to adjust share structure and maintain listing compliance, alongside persistent non-operational status evidenced by stagnant financials through August 2025.